Keyphrases
Oral Administration
100%
Myelin
100%
Experimental Autoimmune Encephalomyelitis
100%
Myelin Basic Protein
100%
High Dose
25%
Oral Tolerance
25%
Specific T Cells
25%
Clinical Trials
12%
T Cell Response
12%
Unresponsiveness
12%
T Cell Proliferation
12%
Interleukin-2
12%
Interleukin-5 (IL-5)
12%
Anergy
12%
Multiple Sclerosis Treatment
12%
Cytokine Response
12%
T-cell Cytokines
12%
Proliferation Response
12%
Repeated Dose
12%
Disease Exacerbation
12%
Protein Feed
12%
Specific Oral Tolerance Induction
12%
Medicine and Dentistry
Oral Drug Administration
100%
Myelin
100%
Experimental Autoimmune Encephalomyelitis
100%
Myelin Basic Protein
100%
Oral Tolerance
37%
Diseases
37%
Drug Megadose
25%
In Vitro
12%
Clinical Trial
12%
T-Cell Response
12%
Disease Exacerbation
12%
T Cell
12%
Multiple Sclerosis
12%
Interleukin 2
12%
Protein Intake
12%
Repeated Drug Dose
12%
Interleukin 5
12%
T Cell Proliferation
12%
Cytokine Response
12%
Pharmacology, Toxicology and Pharmaceutical Science
Experimental Autoimmune Encephalomyelitis
100%
Myelin Basic Protein
100%
Myelin
100%
Diseases
37%
Clinical Trial
12%
Cytokine
12%
Disease Exacerbation
12%
Interleukin 2
12%
Interleukin 5
12%
Multiple Sclerosis
12%
Neuroscience
Myelin
100%
Experimental Autoimmune Encephalomyelitis
100%
Myelin Basic Protein
100%
T Cell
37%
In Vitro
12%
Cell Proliferation
12%
Multiple Sclerosis
12%
Interleukin 2
12%
Interleukin 5
12%
Biochemistry, Genetics and Molecular Biology
Myelin Basic Protein
100%
Myelin
100%
T Cell
37%
Drug Megadose
25%
Clinical Trial
12%
Cell Proliferation
12%
Interleukin 5
12%
Anergy
12%
Interleukin 2
12%
Cytokine Response
12%
Repeated Drug Dose
12%
Immunology and Microbiology
Experimental Autoimmune Encephalomyelitis
100%
Myelin
100%
T Cell
14%
Drug Megadose
14%
T Cell Proliferation
7%
Interleukin 2
7%
Interleukin 5
7%
Cytokine Response
7%
Multiple Sclerosis
7%
Repeated Drug Dose
7%